United Kingdom becomes first country to approve Emory-discovered drug for COVID-19
An Emory-invented antiviral treatment for COVID-19 has been authorized by British regulators, making molnupiravir the first antiviral pill approved for use against SARS-CoV-2. An emergency use application is also under consideration by the U.S. Food and Drug Administration.
RSSRecent News Releases »
Faculty Opinion »
Opinion: COVID has made getting into a top U.S. college even more competitive and this new normal looks here to stay
Afghans want peace. New data show they’re open to a surprising number of options.
COVID variant could mean a brutal March for the US
I've lived in both Americas. Most people everywhere don't want to hate each other
How to reassure Black Americans that the vaccine is safe
Featured Expert »
Andra Gillespie, Politics
Political scientist Andra Gillespie specializes in political mobilization and race and is the author of "The New Black Politician: Cory Booker, Newark and Post-Racial America."
Video »
How customized antibiotic combinations could defeat 'superbugs'
A sneaky form of antibiotic resistance called "heteroresistance" is more widespread than previously appreciated. But tracking heteroresistance might guide the choice of antibiotic combinations that can defeat bacteria regarded as invincible.
Emory in the News »
Rural America’s false sense of security
The Atlantic, Nov. 18
Professor: Learning America's ugly racial history can inspire, not scar, our children
Savannah Morning News, Nov. 17
Opinion: Medicine’s lessons can make movie sets safer
Atlanta Journal-Constitution, Nov. 17
300 minutes a week of moderate exercise may help ward off cancer
New York Times, Nov. 17
- Emory Healthcare CEO Jonathan Lewin in a joint CNN column with Delta CEO Ed Bastian
